losartan has been researched along with peroxynitrous acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Muragaki, Y; Yoshida, K | 1 |
| Chan, JY; Chan, SH; Chang, AY; Hsu, KS; Tsai, CY | 1 |
2 other study(ies) available for losartan and peroxynitrous acid
| Article | Year |
|---|---|
Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits.
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Atherosclerosis; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Heart Rate; Hyperlipidemias; Losartan; Male; Nitric Oxide; Peroxynitrous Acid; Rabbits; Tyrosine; Vasodilator Agents | 2008 |
Brain-derived neurotrophic factor ameliorates brain stem cardiovascular dysregulation during experimental temporal lobe status epilepticus.
Topics: Acetophenones; Animals; Antioxidants; Brain Stem; Brain-Derived Neurotrophic Factor; Cardiovascular System; Cyclic N-Oxides; Enzyme Inhibitors; Epilepsy, Temporal Lobe; Humans; Losartan; NADPH Oxidases; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxynitrous Acid; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, trkB; RNA, Messenger; Spin Labels; Status Epilepticus; Superoxides | 2012 |